The in vitro activities of cyclines (tetracycline, doxycycline, minocycline
, oxytetracycline, and rolitetracycline), macrolides (erythromycin, spiramy
cin, roxithromycin, and lincomycin), quinolones (norfloxacin and ofloxacin)
, rifampin, thiamphenicol, tobramycin, metronidazole, vancomycin, phosphomy
cin, and cephalosporins (cephalexin, cefaclor, cefamandole, cefuroxime, cef
triazone, cefotaxime, and cefoxitin) were evaluated on Plasmodium falciparu
m clones, using an isotopic, micro-drug susceptibility test. Only tetracycl
ines, macrolides, quinoIones, and rifampin demonstrated in vitro activity a
gainst P. falciparum, which increased after a prolonged exposure (96 or 144
h). In the presence of iron (FeCl3), only the activities of tetracyclines
and norfloxacin were decreased. Their in vitro activity against intraerythr
ocytic stages of multidrug-resistant P. falciparum and their efficacy in vi
vo favor the use of antibiotics as antimalarial drugs. However, due to thei
r slow antimalarial action and to the fact that they act better after prolo
nged contact, they probably need to be administered in conjunction with a r
apidly acting antimalarial drug, such as a short course of chloroquine or q
uinine.